ATG12 and Alzheimer disease: Low expression of RBM8A may correlate with the decrease of the components of key complexes (FIP200, Beclin 1, NRBF2, VPS15 and ATG12) in autophagy pathway, which underlie potential novel mechanism contributes to autophagy disorders and AD.